Home » Clinical Trials » Search Clinical Trials

Therapeutic Areas: Hematology

Hemoglobinuria, Paroxysmal Clinical Trials

A listing of Hemoglobinuria, Paroxysmal medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Duarte California 91010

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Los Angeles California 90033

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Whittier California

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Illinois

Chicago Illinois 60612

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

New York

Manhasset New York 11030

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

North Carolina

Durham North Carolina 27710

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Texas

Dallas Texas 75390

A Phase 2 clinical study for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Washington

Seattle Washington 98109

Patients are needed to participate in a clinical research study evaluating BPX-501 and AP1903

Australia

North Gosford, New South Wales

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Parkville

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Canada

Toronto

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Czechia

Prague

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

Denmark

Copenhagen

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Estonia

Tallinn

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Finland

Helsinki

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

France

Montpellier

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Paris

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Poitiers Vienne

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Germany

Essen

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Essen

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Essen 45122

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal

Hanover

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

Heidelberg 69120

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

View More ▼

Ulm

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ulm

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ulm 89075

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

Hungary

Budapest

A clinical trial to evaluate treatments using RA101495 for patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Budapest 1083

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal

Kaposvar 7400

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal

Italy

Napoli

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Rome 00165

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

Turin 10126

Patients are needed to participate in a clinical research study of Treosulfan and Busilvex to evaluate Primary Immunodeficiencies, Inborn Errors of Metabolism, Haemoglobinopathies or Bone Marrow Failure Syndromes

Japan

Bunkyō

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Fukushima

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Fukushima-city Fukushima 960-1295

Patients are needed to participate in a clinical research study evaluating LFG316 for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Hamamatsu

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Kanazawa Ishikawa-Ken

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

View More ▼

Koshigaya Saitama

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Kumamoto

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Nishinomiya

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ogaki Gifu-ken

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Osaka 565-0871

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal

Osakasayama

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Shinjuku Tokyo-To

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Shinjuku-ku Tokyo 160-0023

Patients are needed to participate in a clinical research study evaluating LFG316 for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Suita

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Tokorozawa

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Tokyo 141-8625

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal

Toyohashi

A clinical research study of ALXN1210 and Eculizumab for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Tsukuba 305-8576

Patients are needed to participate in a clinical research study evaluating RO7112689 and Placebo for the treatment of Paroxysmal Hemoglobinuria, Nocturnal